Kidney and Hypertension Unit, Joslin Diabetes Center, One Joslin Place, Boston, MA, 02215, USA.
Harvard Medical School, Boston, MA, USA.
J Nephrol. 2021 Oct;34(5):1521-1529. doi: 10.1007/s40620-021-00994-3. Epub 2021 Mar 8.
Erectile dysfunction, which has been associated with mortality in the general population, is common in individuals on hemodialysis. Our aim was to determine the relationship between erectile dysfunction, coronary artery calcification and mortality in incident hemodialysis patients.
A prospective cohort of incident adult dialysis patients with no history of coronary artery disease underwent coronary artery calcification measurement by ECG-triggered multi-slice computed tomography (MSCT) scan at baseline and at least 12 months later. Erectile dysfunction was determined using the 15-item validated International Index of Erectile Function (IIEF-15) questionnaire.
Erectile dysfunction was prevalent in 83% of patients, with 43% classified as severe erectile dysfunction, 22.4% as moderate erectile dysfunction, and 17.2% as mild erectile dysfunction. The median (IQR) coronary artery calcification score was 43.4 (0.25-353.8) for those with erectile dysfunction and 0 (0-0) for those without erectile dysfunction (p = 0.007). More than half (55.6%) of the patients with erectile dysfunction experienced progression of coronary artery calcification compared to 14.3% of patients without erectile dysfunction (p = 0.05). Mortality was 21% during an average follow-up of 5.2 (1.3) years. Twenty-three percent of patients with erectile dysfunction died compared to 10% of people without erectile dysfunction (p = 0.4). Erectile dysfunction was not significantly associated with mortality [HR 1.2 (1.3), p = 0.87].
Erectile dysfunction is common in individuals who start dialysis. It is significantly associated with an increased coronary artery calcification score, however, it is not associated with increased mortality in incident dialysis patients with no history of coronary artery disease.
勃起功能障碍与普通人群的死亡率相关,在血液透析患者中较为常见。我们旨在确定勃起功能障碍与冠状动脉钙化和血液透析患者死亡率之间的关系。
一项前瞻性队列研究纳入了无冠状动脉疾病史的成年透析患者,他们在基线时和至少 12 个月后接受了心电图触发的多层螺旋 CT(MSCT)扫描以测量冠状动脉钙化。使用经过验证的 15 项国际勃起功能指数(IIEF-15)问卷确定勃起功能障碍。
83%的患者存在勃起功能障碍,其中 43%为严重勃起功能障碍,22.4%为中度勃起功能障碍,17.2%为轻度勃起功能障碍。有勃起功能障碍的患者的冠状动脉钙化评分中位数(IQR)为 43.4(0.25-353.8),无勃起功能障碍的患者为 0(0-0)(p=0.007)。与无勃起功能障碍的患者相比,超过一半(55.6%)有勃起功能障碍的患者发生冠状动脉钙化进展,而无勃起功能障碍的患者中只有 14.3%(p=0.05)。在平均 5.2(1.3)年的随访期间,死亡率为 21%。有勃起功能障碍的患者中有 23%死亡,而无勃起功能障碍的患者中有 10%(p=0.4)。勃起功能障碍与死亡率无显著相关性[HR 1.2(1.3),p=0.87]。
开始透析的个体中勃起功能障碍很常见。它与冠状动脉钙化评分增加显著相关,但与无冠状动脉疾病史的血液透析患者的死亡率增加无关。